Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday broker round-up

Thu, 04th Dec 2014 08:46

Aberdeen: Charles Stanley downgrades to 'hold'.Afren: Canaccord reduces target price from 115p to 65p, while staying with its 'speculative buy' recommendation.Amino Technologies: Northland moves target price from 120p to 130p and retains a 'buy' recommendation.Belgravium Technologies: WH Ireland lowers target price from 8p to 6p and keeps its 'buy' recommendation.Bellway: Panmure increases target price from 1756p to 1991p and maintains a 'buy' recommendation.Betfair: PeelHunt places both its target price (prev.: 1201p) and its 'hold' recommendation under review.BG Group: Canaccord reduces target price from 1520p to 1258p, while staying with its 'buy' recommendation.BHP Billiton: UBS reduces target price from 2100p to 2000p, while keeping a 'buy' recommendation. Investec reduces target price from 1724p to 1599p and maintains a 'hold' recommendation.Borders & Southern Petroleum: Canaccord lowers target price from 15p to 9p and keeps a 'hold' recommendation.BP: canaccord reduces target price from 560p to 500p and retains a 'buy' recommendation.Bovis Homes Group: Panmure ups target price from 956p to 1005p and leaves its 'buy' recommendation.Cairn Energy: canaccord cuts target price from 200p to 185p and maintains a 'hold' recommendation.Carr's Milling: Investec ups target price from 1900p to 1918p and reiterates a 'buy' recommendation.Chesnara: Canaccord ups target price from 335p to 360p and upgrades from 'hold' to 'buy'.Clipper Logistics: Numis moves target price from 170p to 180p and upgrades from 'add' to 'buy'.Consort Medical: N+1 Singer reduces target price from 950p to 806p, while upgrading from 'hold' to 'buy'.CVS Group: PeelHunt ups target price from 400p to 475p and maintains a 'buy' recommendation.Debenhams: N+1 Singer lowers target price from 78p to 75p and downgrades to 'hold'.Eland Oil & Gas: Canaccord cuts target price from 185p to 160p, while keeping a 'buy' recommendation.EnQuest: Canaccord lowers target price from 100p to 90p and keeps a 'hold' recommendation.Falkland Oil & Gas: Canaccord lowers target price from 45p to 35p and stays with its 'buy' recommendation.Faroe Petroleum: Canaccord lowers target price from 145p to 140p and stays with its 'buy' recommendation.Genel Energy: Canaccord cuts target price from 1050p to 1000p and retains a 'buy' recommendation.Glencore Xstrata: Liberum downgrades to 'sell' with a target price of 280p.Green Dragon Gas: Cantor Fitzgerald reduces target price from 952p to 885p and stays with its 'buy' recommendation.Gulf Keystone: Canaccord lowers target price from 70p to 60p and keeps a 'hold' recommendation.Gulfsands Petroleum: Canaccord reduces target price from 110p to 30p and reiterates its 'hold' recommendation.Hikma Pharmaceuticals: Panmure raises target price from 1800p to 2120p and keeps a 'hold' recommendation.Hill & Smith: PeelHunt initiates with a target price of 660p and a 'buy' recommendation.Hunting: Numis reduces target price from 555p to 487p, retaining a 'reduce' rating.Igas Energy: canaccord cuts target price from 150p to 125p, retaining its 'buy' recommendation.Ithaca Energy: Canaccord lowers target price from 160p to 150p and keeps a 'buy' recommendation.Lekoil: Canaccord lowers target price from 75p to 70p and retains a 'speculative buy' recommendation.Lloyds Banking Group: Espirito Santo shifts target price from 70p to 72p and maintains its 'sell' recommendation.Man Group: UBS ups target price from 132p to 156p and reiterates a 'buy' recommendation.Next Fifteen Communications: Canaccord shifts target price from 161p to 166p and maintains a 'buy' recommendation.Ophir Energy: Canaccord reduces target price from 275p to 200p and stays with its 'buy' recommendation.Persimmon: Panmure raises target price from 1300p to 1455p and keeps a 'hold' recommendation.Petra Diamonds: Investec moves target price from 251p to 263p and retains a 'buy' recommendation.Petro Neft: Canaccord shifts target price from 8p to 9.5p, upgrading from 'hold' to 'buy'.Premier Oil: Canaccord cuts target price from 250p to 215p and maintains a 'hold' recommendation.Redrow: Panmure ups target price from 306p to 324p and maintains a 'buy' recommendation.Robert Walters: Panmure ups target price from 329p to 353p and upgrades to 'buy'.Rotork: Liberum reduces target price from 2500p to 1910p and keeps a 'sell' recommendation.Royal Bank of Scotland: Espirito Santo ups target price from 320p to 385p and stays with its 'neutral' rating.Royal Dutch Shell: Canaccord reduces target price from 2800p to 2480p, while leaving its 'buy' recommendation unchanged.Sage Group: Citi ups target price from 450p to 475p and reiterates a 'buy' recommendation. UBS ups target price from 390p to 410p and retains its 'neutral' rating.Smith (DS): Investec places its target price (prev.: 350p) under review, while staying with its 'buy' recommendation.SOCO International: Canaccord cuts target price from 380p to 320p and reiterates a 'hold' recommendation.Standard Chartered: Espirito Santo reduces target price from 1575p to 1150p and keeps its 'buy' recommendation.Taylor Wimpey: Panmure shifts target price from 116p to 120p and retains a 'hold' recommendation.TUI Travel: Numis downgrades from 'add' to 'hold' with a target price of 425p.
More News
3 Jan 2017 08:10

Consort Medical splutters as BAT stubs out Voke programme

(ShareCast News) - British American Tobacco has terminated an agreement with Consort Medical over the manufacture of nicotine inhalers for its Voke development programme. Consort, which said it was in "constructive dialogue" with BAT's Nicovations arm and product developer Kind Consumer over the fut

Read more
6 Dec 2016 08:18

Consort Medical posts good growth in first half

(ShareCast News) - Single source drug and delivery device company Consort Medical announced its interim results for the six months to 31 October on Tuesday. The London-listed firm said group revenue increased to £144.9m from £135.5m, representing underlying growth of 2.0% and reported growth of 6.9%

Read more
25 Nov 2016 09:07

Consort Medical appoints new CFO

(ShareCast News) - Consort Medical, a global provider of manufacturing solutions for drugs, announced that it has appointed Paul Hayes as group Finance Director of the Vitec Group. Hayes is taking over the position of chief financial officer from Richard Cotton as well joining the board as executive

Read more
27 Oct 2016 07:45

Consort Medical Welcomes Cimzia Autoclicks Launch On NHS

Read more
14 Oct 2016 12:23

Consort Medical's Bespak inks new agreement

(ShareCast News) - Consort medical, a global single source drug and Delivery device company (CDMO), has announced that its Bespak division has entered into an agreement with a biopharmaceutical company. Bespak manufactures drug delivery devices for pharmaceutical partner companies including respirat

Read more
19 Sep 2016 09:07

Consort Notes European Nod For Bespak Technology-Using Product

Read more
7 Sep 2016 08:43

Consort Medical signs agreement with AstraZeneca

(ShareCast News) - Consort medical, a provider of advanced technology for drugs, has signed a new contract with pharmaceutical giant AstraZeneca for the supply of its Bespak respiratory devices. AstraZeneca and Bespak have agreed to enter into a multi-year agreement for the scale-up and supply of Be

Read more
7 Sep 2016 07:03

Consort Medical Sees Little Brexit Impact; Signs Deal With AstraZeneca

Read more
23 Jun 2016 15:19

Director dealings: Derwent London CEO sells just ahead of Brexit vote

(ShareCast News) - Derwent London chief executive John Burns has sold £1.5m of the FTSE 250 real estate investor's shares in the week just before the EU referendum which could seriously lift or undermine the company's shares. In Wednesday's sale, which comes two days before results for Britain's ref

Read more
17 Jun 2016 09:29

Numis places Consort Medical 'under review'

(ShareCast News) - Consort Medical's shares were put 'under review' by Numis after the company reported its full year results. The pharmaceutical device frim on Thursday reported full year earnings before interest and tax rose 47.6% to £37m as revenues gained 49.8% to £276.9m, driven by a strong per

Read more
16 Jun 2016 14:52

Consort Medical's annual revenues rise as a product launch is delayed

(ShareCast News) - Consort Medical, a pharmaceutical device company, revealed higher full year profits on Thursday due to organic growth and an acquisition. Revenues rose 49.8% to £276.9m from £184.8m the previous financial year. Bespak, the company's drug device manufacturing subsidiary, continued

Read more
16 Jun 2016 07:37

Consort Medical Profit Doubles As Progress Made On DEV610 Programme

Read more
9 Jun 2016 15:04

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
5 Apr 2016 08:32

BROKER RATINGS SUMMARY: Liberum Upgrades Babcock To Hold From Sell

Read more
22 Feb 2016 16:51

Consort Medical agrees partnership and invests in Precision Ocular

(ShareCast News) - Consort Medical has made a £3.3m equity investment for a 13.7% stake in retinal therapeutics specialist Precision Ocular and agreed a development and manufacturing partnership. London-based Precision Ocular has developed retinal treatments that are designed to access specific sma

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.